Enhancing the Value of Your Development Candidate with Early Optimization
Date:
Thursday, 13 March 2025
Time:
11.30am – 13.30pm
Location:
Event Highlights
Keynote Presentation from Early Development Services
Noel Smith, Director, R&D Early Development Services
In today's fast-paced environment with dynamic changes and increasingly complex molecular structures, evolving strategies are crucial for the commercial success of therapeutic advancements. Our expertise in the early development of biologics therapeutics enables us to explore and implement key strategies such as immunogenicity risk assessment, manufacturability and protein production, to overcome challenges and streamline early-stage drug development processes.
Keynote Presentation from Drug Product Services
Monika Geiger, Associate Director, Drug Product Formulation Development
Early development phases of biologics often lack comprehensive understanding of physicochemical characteristics and liabilities, posing risks to successful and timely development. Our strategies address these risks by rapidly evaluating multiple candidates with minimal material, utilizing comprehensive solution condition screening, high throughput candidate ranking, and automated data visualization workflows, ensuring successful scale-up and formulatability.
Networking
Connect with industry colleagues over a lovely apero.
1:1 Partnering Meetings
Following the talks, attendees can book follow-up 1–1 meetings with the Lonza team for more personalized discussions.
About Lonza Biologics
A fully integrated CDMO that offers innovative development and manufacturing services and technologies from late-phase drug discovery to market supply, from drug substance to drug product across a variety of molecule types. Click here for more details.
Please complete the form to register your interest.
